SBC Medical Group Holdings Incorporated is a forward-thinking healthcare innovator dedicated to enhancing patient care through state-of-the-art medical technologies and integrated solutions. The company focuses on diagnostics and disease management, leveraging advanced research to improve treatment effectiveness and health outcomes. With a commitment to quality and ongoing innovation, SBC is strategically positioned to address pressing healthcare challenges, offering sustainable growth and substantial long-term value to its investors and stakeholders.
| Revenue (TTM) | $169.34M |
| Gross Profit (TTM) | $119.90M |
| EBITDA | $63.73M |
| Operating Margin | 41.10% |
| Return on Equity | 16.50% |
| Return on Assets | 11.30% |
| Revenue/Share (TTM) | $1.65 |
| Book Value | $2.42 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -47.10% |
| Quarterly Revenue Growth (YoY) | -9.00% |
| Shares Outstanding | 0 |
| Float | $12.27M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently expanding